Praxis Precision Medicines, Inc. Common Stock (PRAX) Financials
Key financial figures for Praxis Precision Medicines, Inc. Common Stock (Q1 2026).
- Revenue
- $0
- Net Income
- -$93M
- EPS
- $-3.20
- Total Assets
- $1.5B
- Operating Cash Flow
- -$86M
Full income statement, balance sheet, and cash flow for Praxis Precision Medicines, Inc. Common Stock on SentiSense.